O
CFRX

OppenheimerFunds’s ContraFect Corporation CFRX Stock Holding History

OppenheimerFunds’s Portfolio CFRX Stock Details CFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-17
Closed -$21K – 1826
2018
Q4 		$21K Buy
+17
New +$27K ﹤0.01% 1785

Other funds holding CFRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OppenheimerFunds's CFRX Position: Q1 2019 in Review

OppenheimerFunds sold out of ContraFect Corporation (CFRX) in Q1 2019, closing a stake of 17 shares — an estimated $21K sold.

OppenheimerFunds first reported a position in CFRX in Q4 2018 and held it in 1 quarter. The position peaked at $21K in Q4 2018. 37 funds tracked by Wall St. Rank hold CFRX as of Q1 2019.

  • OppenheimerFunds reported no remaining ContraFect Corporation position as of Q1 2019 after selling out during the quarter.
  • OppenheimerFunds sold 17 ContraFect Corporation shares in Q1 2019, an estimated $21K.
  • OppenheimerFunds first reported a position in ContraFect Corporation in Q4 2018 and held it in 1 quarter.
  • OppenheimerFunds's ContraFect Corporation position peaked at $21K in Q4 2018.
  • 37 funds tracked by Wall St. Rank held ContraFect Corporation as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.